Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Christopher Jones S"'
Autor:
Singh, Pritpal, Nayernama, Afrouz, Christopher Jones, S, Amiri Kordestani, Laleh, Fedenko, Katherine, Prowell, Tatiana, Bersoff-Matcha, Susan J
Publikováno v:
Journal of Oncology Pharmacy Practice; Jun2020, Vol. 26 Issue 4, p923-928, 6p, 2 Charts
Autor:
Crew, Page E., McNamara, Lucy, Waldron, Peter E., McCulley, Lynda, Christopher Jones, S., Bersoff-Matcha, Susan J.
Publikováno v:
Journal of Infection; Mar2020, Vol. 80 Issue 3, p350-371, 22p
Publikováno v:
Journal of Oncology Pharmacy Practice; Dec2019, Vol. 25 Issue 8, p1817-1822, 6p, 1 Chart
Autor:
McBride L; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, Silver Spring, MD, USA., Woronow D; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, Silver Spring, MD, USA., Nayernama A; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, Silver Spring, MD, USA., Christopher Jones S; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Jul; Vol. 27 (5), pp. 1315-1316. Date of Electronic Publication: 2021 May 14.
Autor:
Lardieri A; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., McCulley L; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Christopher Jones S; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Woronow D; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
American journal of hematology [Am J Hematol] 2018 Oct; Vol. 93 (10), pp. E333-E336. Date of Electronic Publication: 2018 Jul 30.
Autor:
Mao, Jessica1 (AUTHOR), Chang, Allison Komatsu2 (AUTHOR), Chin, Stephen3 (AUTHOR), Preet, Komal4 (AUTHOR), Torosyan, Nare3 (AUTHOR), Sarkissian, Sarmen5 (AUTHOR), Ebinger, Joseph1 (AUTHOR) joseph.ebinger@csmc.edu
Publikováno v:
Journal of Medical Case Reports. 4/16/2024, Vol. 18 Issue 1, p1-6. 6p.
Autor:
Martínez-Montalvo, Carlos M.1, Cruz-Cuevas, José D.2 jcruz@lacardio.org, Salazar, Érika M.3, Villalobos-Torres, Yaiza A.4, Carvajal, Lida P.5
Publikováno v:
Revista Colombiana de Cardiología. ene/feb2024, Vol. 31 Issue 1, p65-69. 5p.
Publikováno v:
Biomedicines; Sep2024, Vol. 12 Issue 9, p1971, 19p
Publikováno v:
Annals of Pharmacotherapy; Sep2024, Vol. 58 Issue 9, p947-955, 9p
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2013 Jan; Vol. 56 (1), pp. 165. Date of Electronic Publication: 2012 Sep 12.